Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 16;82(9):390.
doi: 10.1007/s00284-025-04370-3.

Unravelling the Gut-Microbiome-Brain Axis: Implications for Infant Neurodevelopment and Future Therapeutics

Affiliations
Review

Unravelling the Gut-Microbiome-Brain Axis: Implications for Infant Neurodevelopment and Future Therapeutics

Absar Talat et al. Curr Microbiol. .

Abstract

The microbiome-gut-brain axis signifies the intricate interplay between gut microbiome and brain, facilitated by bidirectional communication channels. The brain modulates gut function through the hypothalamic-pituitary-adrenal axis and the autonomic nervous system, while the gut influences central nervous system (CNS) function through microbial metabolites, neurotransmitters, and gut hormones. Early brain development in infants is shaped by mother to neonate microbiome transmission, mode of birth, gestational length, breastfeeding, maternal and infant antibiotic exposure, and acquired infections. Dysbiosis in the gut microbiome is associated with various neurodevelopmental disorders in children such as attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). In this review, we elucidate the pivotal role of the microbiome-gut brain axis in a child's neural development, exploring factors modulating this intricate interaction. Furthermore, we discuss the potential future therapeutic avenues that can support optimal neurodevelopment, such as probiotics, prebiotics, synbiotics, postbiotics, CRISPR/Cas9, fecal microbiota transplant, and phage therapy.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing Interests: The authors report there are no competing interests to declare.

Similar articles

References

    1. Sender R, Fuchs S, Milo R (2016) Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 14(8):e1002533. https://doi.org/10.1371/JOURNAL.PBIO.1002533 - DOI - PubMed - PMC
    1. Socała K, Doboszewska U, Szopa A et al (2021) The role of microbiota–gut–brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 172:105840. https://doi.org/10.1016/J.PHRS.2021.105840 - DOI - PubMed
    1. Parker A, Fonseca S, Carding SR (2020) Gut microbes and metabolites as modulators of blood–brain barrier integrity and brain health. Gut Microbes 11:135. https://doi.org/10.1080/19490976.2019.1638722 - DOI - PubMed
    1. Hajjo R, Sabbah DA, Al Bawab AQ (2022) Unlocking the potential of the human microbiome for identifying disease diagnostic biomarkers. Diagnostics (Basel) 12(7):1742. https://doi.org/10.3390/DIAGNOSTICS12071742 - DOI - PubMed
    1. Caprara GL, von Ameln LO, Martins AF et al (2024) Gut microbiota transfer evidence from mother to newborn. Eur J Pediatr 183:749–757. https://doi.org/10.1007/S00431-023-05341-1 - DOI - PubMed

LinkOut - more resources